Should pharmacists be able to provide the pill over the counter?

Healthed

writer

Healthed

Healthed

Phoebe Roth, The Conversation

As we head towards a federal election, the Labor government recently announced a funding package worth A$573 million for women’s health.

The funding includes $100 million to support two national trials for pharmacies to provide the oral contraceptive pill and treatments for uncomplicated urinary tract infections over the counter.

The question of whether or not pharmacists should be able to provide the oral contraceptive pill without a prescription from a GP has long been a topic of debate.

We asked five experts for their thoughts. Should pharmacists be able to provide the pill over the counter without a script?

Four out of five said yes. Here are their detailed responses.

The Conversation

Phoebe Roth, Health Editor, The Conversation

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rod Baber

Prof Rod Baber

Menopausal Hormone Therapy - What Dose of Estrogen is Best?

Dr Adam Nelson

Dr Adam Nelson

Cardiovascular Benefits of GLP1s – New Evidence

Dr Kathleen McNamee, Prof Sonia Grover

Dr Kathleen McNamee, Prof Sonia Grover

Oral Contraceptive Pill in Teens

Prof Andrew Sindone

Prof Andrew Sindone

RSV and the Heart

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Healthed

writer

Healthed

Test your knowledge

Recent articles

Latest GP poll

Has a clinic you work at ever received an unfair negative online review?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease